New Zealand markets closed

Blueprint Medicines Corporation (BPMC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
107.19+0.19 (+0.18%)
At close: 04:00PM EDT
107.91 +0.72 (+0.67%)
After hours: 05:27PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.71B
Enterprise value 6.39B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)26.03
Price/book (mrq)51.39
Enterprise value/revenue 25.64
Enterprise value/EBITDA -13.59

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 395.61%
S&P500 52-week change 322.38%
52-week high 3110.93
52-week low 343.89
50-day moving average 391.24
200-day moving average 371.12

Share statistics

Avg vol (3-month) 3833.1k
Avg vol (10-day) 3849.01k
Shares outstanding 562.62M
Implied shares outstanding 661.23M
Float 860.61M
% held by insiders 10.86%
% held by institutions 1105.45%
Shares short (15 Apr 2024) 44.25M
Short ratio (15 Apr 2024) 45.9
Short % of float (15 Apr 2024) 47.62%
Short % of shares outstanding (15 Apr 2024) 46.76%
Shares short (prior month 15 Mar 2024) 45.15M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -102.15%
Operating margin (ttm)-82.01%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)282.21M
Revenue per share (ttm)4.63
Quarterly revenue growth (yoy)51.90%
Gross profit (ttm)N/A
EBITDA -430M
Net income avi to common (ttm)-288.29M
Diluted EPS (ttm)-4.82
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)710.64M
Total cash per share (mrq)11.61
Total debt (mrq)774.12M
Total debt/equity (mrq)592.70%
Current ratio (mrq)N/A
Book value per share (mrq)2.14

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A